Professor of Medicine, Washington University St Louis
Endocrinology
Dr. Janet B. McGill, MD
|
|
Give Review
Janet McGill practices Endocrinology. She received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Women's Health" and "Fellow (FACE)". Janet McGill is a published doctor and has 60 publications published. The lastest was: 'Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study).'
Publications
- Strategies for glucose control in a study population with Diabetes, renal disease and anemia (Treat study).
- MAXIMIZING PATIENT SAFETY With NEWLY APPROVED THERAPIES: FOCUS ON SGLT2 INHIBITORS.
- Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial.
- Shoulder limited joint mobility in people with Diabetes mellitus.
- Safety and efficacy of hyperglycemia urgency order set.
- Upper extremity impairments, pain and disability in patients with Diabetes mellitus.
- Prevention of inpatient hypoglycemia With a real-time informatics alert.
- Anti-Diabetes therapy: safety considerations for patients with impaired kidney function.
- The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review.
- Linagliptin added to sulphonylurea in uncontrolled type 2 Diabetes patients with moderate-to-severe renal impairment.
- Impact of Sex on the Heart's Metabolic and Functional Responses to Diabetic Therapies.
- Options for Prandial Glucose Management in Type 2 Diabetes Patients Using Basal Insulin: Addition of a Short-acting GLP-1 Analogue versus Progression to Basal-Bolus Th...
- Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1C Levels in T1D Exchange Clinic Registry Participants.
- Weight-Bearing Versus Nonweight-Bearing Exercise for Persons With Diabetes and Peripheral Neuropathy: A Randomized Controlled Trial.
- Hyperandrogenism and Intersex Controversies in Women's Olympics.
- Prediction and prevention of treatment-related inpatient Hypoglycemia.
- Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 Diabetes: a patient-level pooled analysis.
- Predictors of fatal and nonfatal cardiovascular events in patients with type 2 Diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduc...
- Sex and Type 2 Diabetes: Obesity-Independent Effects on Left Ventricular Substrate Metabolism and Relaxation in Humans.
- Changes in Insulin Sensitivity Following Administration of the Clinically-Used Low-Dose Pressor, Norepinephrine.
- Potentiation of abnormalities in myocardial Metabolism with the development of diabetes in women with obesity and insulin resistance.
- Approach to obesity in patients With pelvic floor dysfunction.
- Selecting among ADA/EASD tier 1 and tier 2 treatment options.
- Insights from the Liraglutide Clinical Development Program--the Liraglutide Effect and Action in Diabetes (LEAD) studies.
- Improving microvascular outcomes in patients with Diabetes through management of hypertension.
- Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 Diabetes.
- Progress and controversies: treating Obesity and insulin resistance in the context of hypertension.
- How to make exercise counseling more effective: lessons from rural America.
- Effect of LDL cholesterol and treatment With losartan on end-stage renal disease in the RENAAL study.
- Inpatient glycemic control on the vascular surgery service.
- The changing landscape of type 2 Diabetes: the role of incretin-based therapies in managed care outcomes.
- Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 Diabetes: results from ...
- The decrease in microalbuminuria With carvedilol therapy is not enhanced by concurrent use of a statin.
- Psychosocial factors in patients With chronic kidney disease.
- How the Diabetic eye loses vision.
- Continued use of an integrated meter With electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.
- Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 Diabetes.
- Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with Diabetes.
- Epidemiology of Obesity and chronic kidney disease.
- Anemia and the role of erythropoietin in Diabetes.
- Alterations in left ventricular structure and function in Type-1 diabetics: a focus on left atrial contribution to function.
- Sertraline for prevention of depression recurrence in Diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
- Increased myocardial fatty acid Metabolism in patients with type 1 diabetes mellitus.
- Paradoxical increase in ventricular torsion and systolic torsion rate in Type I diabetic patients under tight glycemic control.
- The effect of ruboxistaurin on nephropathy in type 2 Diabetes.
- A multilevel ecological approach to promoting walking in rural communities.
- The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 Diabetes mellitus.
- Rationale--Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients With chronic kidney disease.
- Kidney Early Evaluation Program (KEEP). Findings from a community screening program.
- Lack of effect of sucralose on glucose homeostasis in subjects with type 2 Diabetes.
- Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 Diabetes: a randomized, parallel-group, 24-week study.
- Fat-free foods supplemented With soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol.
- Depression and coronary heart disease in women with Diabetes.
- Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
- Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans.
- Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 Diabetes mellitus.
- Anxiety and poor glycemic control: a meta-analytic review of the literature.
- Severe ovarian hyperstimulation syndrome in patients with autoimmune Disorders: a report of two cases.
- Retinopathy and clinical outcomes in patients with type 2 Diabetes mellitus, chronic kidney disease, and anemia.
Schools
Mi State Univ Coll Human Med
Beaumont Hospital Royal Oak
William Beaumont Hospital
Washington University
Conditions Treated
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Diabetes Insipidus
- View All
Doctors Specialties
- Diabetes Medicine
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Women's Health
- Fellow (FACE)
Education
-
Washington University - Barnes-Jewish Hospital -
William Beaumont Hospital -
Michigan State University College of Human Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1811915325 | |
| NPPES Provider LastName | MCGILL | |
| NPPES Provider FirstName | JANET | |
| NPPES Provider ZIPCode | 631101020 | |
| NPPES Provider State | MO | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 967.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811915325 |
| Last Name Of The Provider | MCGILL |
| First Name Of The Provider | JANET |
| View All |
Similar Doctors
|
|
Dr. Naman A. Ghazal-Albar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj M. Sajid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Clutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clay F. Semenkovich, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amy E. Riek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paraskevi Mentzelopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irini E. Veronikis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Humaira K. Naseer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad R. Rofougaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles Kilo Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto Civitelli, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|